MedLumics, Spanish medical device company closes €34M round
22/03/2017
Diego Gutiérrez
MedLumics, Spanish medical device company closes €34M round
This financing round is the largest financing round in the history of medical technology in Spain and is one of the largest rounds in Europe in the last year. Investors that have backed the company include Ysios Capital and Caixa Capital Risk.
About MedLumics

Founded in 2009, MedLumics is a company that produces camera-based cardiac devices that provide a real-time view of the heart's condition. Its Argia® technology platform, based on integrated optics, combines electrical and optical components on a small silicon chip. These products enable physicians to improve diagnostic and therapeutic procedures through optical tissue assessment.

"The Madrid-based company has already received a €3.5M round in 2011, which involved Caixa capital Risk e Ysios Capital"comments Diego Gutiérrez, corporate finance expert at Abra- invest

About the investment round

This investment round will bring its main product to the market. AblaView is the company's main product and is aimed at the treatment of atrial fibrillation, in the field of arrhythmias. AblaView represents a qualitative leap in the treatment of this disease, as for the first time doctors will have a device that will allow them to see the effect of their therapies in real time and directly.

The round was led by Edmond de Rothschild Investment Partners (EdRIP), and the new investors also include Seroba Life Sciences and Innogest Capital as well as Ysios Capital Partners and Caixa Capital Risc. As a result of the capital increase, Olivier Litzka representing EdRIP, Claudio Rumazza for Innogest and James Greene for Seroba have joined the board together with the founder, Eduardo Margallo and the representative of Ysios Capital, Josep Lluís Sanfeliu.

"The entry of European investors is a great opportunity for Medlumcis, which gains perspective and ease of entry into new markets. In addition, some of the investors, such as Seroba Life Science, have great experience in bringing medical technology to the market," says Diego Gutierrez.

Photonics technology devices market

 

 Other posts that may interest you

Inkemia, which is listed on the Mab, carries out a capital increase, opens a subsidiary and prepares to jump to the English Mab.

Sanitas buys Helthia to enter the world of digitalisation

If you are looking for investors, you want to buy or selling a companyplease contact us. Abra-Invest has a team of experts in each area at your disposal. Call +34 946424142 or fill in the contact form.

Lastest news

Latest transactions in the Machine Learning sector

Las recientes adquisiciones en el sector del Machine learning ponen de relieve la creciente importancia estratégica de la innovación impulsada por la IA. Las empresas están invirtiendo mucho en plataformas avanzadas de análisis y datos, centrándose en integrar...

Latest transactions in the Data Analytics sector

Se han realizado diferentes adquisiciones estratégicas de empresas del sector de Data Analysis en los últimos meses, lo que pone de relieve el creciente énfasis en soluciones innovadoras y capacidades mejoradas. Las empresas recurren cada vez más a las adquisiciones...

Software Application 2023 Sector Valuation Report

Sector Software Application: análisis del mercado y tendencias del sector El Informe de Valoración de la Industria del Software Application 2023, elaborado por los asesores de compraventa de empresas del sector Tech de Baker Tilly, ofrece un análisis detallado y...

Latest transactions in the Artificial Intelligence sector

El sector de la inteligencia artificial está siendo testigo de una dinámica oleada de adquisiciones, reflejo de su rápida evolución y de su creciente importancia en diversos sectores. La compraventa de empresas del sector tecnológico pone de relieve los movimientos...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42